Intrawound Vancomycin Powder in Primary Total Hip Arthroplasty Increases Rate of Sterile Wound Complications
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: Total hip arthroplasty (THA) is a successful surgery for the treatment of hip osteoarthritis; however, the risk of a post-operative prosthetic joint infection (PJI) remains at 1% to 2%. The purpose of this study was to investigate the safety profile of using vancomycin powder (VP) to reduce infection rates by reviewing acute postoperative complications. Materials and Methods: A retrospective review of 265 consecutive patients undergoing THA was performed. The first 128 patients, the control group, did not receive VP, and the subsequent 137 patients, the VP group, received VP at the time of wound closure. Patient demographic data, medical comorbidities, and perioperative information were compared. Results: The primary outcome was a post-operative surgical complication within 90 days from surgery. The control and VP group’s demographic, medical comorbidities and perioperative information data were statistically similar. Deep infection rate in the control group was 5.5%, whereas the deep infection rate in the VP group was 0.7% (P=0.031). Sterile wound complication rate was 4.4% in the VP group, and 0% in the control group (P=0.030). Remaining complications were not statistically different between the groups. Conclusion: VP was associated with an increase rate of sterile wound complications compared to the control group. The rate of PJI was decreased with the use of VP. We do not recommend for or against the use of VP at time of wound closure to prevent PJI, and higher powered studies will need to be performed to demonstrate the efficacy of VP.
Abstract
Purpose: Total hip arthroplasty (THA) is a successful surgery for the treatment of hip osteoarthritis; however, the risk of a post-operative prosthetic joint infection (PJI) remains at 1% to 2%. The purpose of this study was to investigate the safety profile of using vancomycin powder (VP) to reduce infection rates by reviewing acute postoperative complications. Materials and Methods: A retrospective review of 265 consecutive patients undergoing THA was performed. The first 128 patients, the control group, did not receive VP, and the subsequent 137 patients, the VP group, received VP at the time of wound closure. Patient demographic data, medical comorbidities, and perioperative information were compared. Results: The primary outcome was a post-operative surgical complication within 90 days from surgery. The control and VP group’s demographic, medical comorbidities and perioperative information data were statistically similar. Deep infection rate in the control group was 5.5%, whereas the deep infection rate in the VP group was 0.7% (P=0.031). Sterile wound complication rate was 4.4% in the VP group, and 0% in the control group (P=0.030). Remaining complications were not statistically different between the groups. Conclusion: VP was associated with an increase rate of sterile wound complications compared to the control group. The rate of PJI was decreased with the use of VP. We do not recommend for or against the use of VP at time of wound closure to prevent PJI, and higher powered studies will need to be performed to demonstrate the efficacy of VP.
참고문헌 (30)
- Kapadia BH, "Periprosthetic joint infection", Lancet, 387, pp.386~394 (2016)[DOI]
- Garcia-Cimbrelo E, "Total hip arthroplasty with use of the cementless Zweymuller Alloclassic system. A ten to thirteen-year follow-up study", J Bone Joint Surg Am, 85-A, pp.296~303 (2003)
- D'Angelo F, "Seven to twelve year results with Versys ET cementless stem. A retrospective study of 225 cases", Hip Int, 20, pp.81~86 (2010)[DOI]
- Castoldi F, "Ten-year survivorship of the Anatomique Benoist Girard I total hip arthroplasty", J Arthroplasty, 22, pp.363~368 (2007)[DOI]
- Herrera A, "Seven to 10 years followup of an anatomic hip prosthesis: an international study", Clin Orthop Relat Res, (423), pp.129~137 (2004)
- Dale H, "Increasing risk of revision due to deep infection after hip arthroplasty", Acta Orthop, 80, pp.639~645 (2009)[DOI]
- Kurtz SM, "Infection burden for hip and knee arthroplasty in the United States", J Arthroplasty, 23, pp.984~991 (2008)[DOI]
- Zmistowski B, "Unplanned readmission after total joint arthroplasty: rates, reasons, and risk factors", J Bone Joint Surg Am, 95, pp.1869~1876 (2013)[DOI]
- Ilchmann T, "Risk of infection in primary, elective total hip arthroplasty with direct anterior approach or lateral transgluteal approach: a prospective cohort study of 1104 hips", BMC Musculoskelet Disord, 17, pp.471~ (2016)[DOI]
- Kurtz SM, "Economic burden of periprosthetic joint infection in the United States", J Arthroplasty, 27(8 Suppl), pp.61~65 (2012)[DOI]
- Parvizi J, "Periprosthetic joint infection: the algorithmic approach and emerging evidence", Instr Course Lect, 64, pp.51~60 (2015)
- Shahi A, "Prevention of periprosthetic joint infection", Arch Bone Jt Surg, 3, pp.72~81 (2015)
- AlBuhairan B, "Antibiotic prophylaxis for wound infections in total joint arthroplasty: a systematic review", J Bone Joint Surg Br, 90, pp.915~919 (2008)[DOI]
- Hanssen AD, "Local antibiotic delivery systems: where are we and where are we going?", Clin Orthop Relat Res, (437), pp.111~114 (2005)
- Kang DG, "Intrasite vancomycin powder for the prevention of surgical site infection in spine surgery: a systematic literature review", Spine J, 15, pp.762~770 (2015)[DOI]
- Edelstein AI, "Intra-articular vancomycin powder eliminates methicillin-resistant S. aureus in a rat model of a contaminated intra-articular implant", J Bone Joint Surg Am, 99, pp.232~238 (2017)[DOI]
- Otte JE, "Intrawound vancomycin powder reduces early prosthetic joint infections in revision hip and knee arthroplasty", Surg Technol Int, 30, pp.284~289 (2017)
- Ghobrial GM, "Complications from the use of intrawound vancomycin in lumbar spinal surgery: a systematic review", Neurosurg Focus, 39, pp.E11~ (2015)
- Hansen BJ, "The Rottinger approach for total hip arthroplasty: technique and review of the literature", Curr Rev Musculoskelet Med, 4, pp.132~138 (2011)[DOI]
- Parvizi J, "Proceedings of the International Consensus on Periprosthetic Joint Infection", Bone Joint J, 95-B, pp.1450~1452 (2013)[DOI]
- Bakhsheshian J, "The use of vancomycin powder in modern spine surgery: systematic review and meta-analysis of the clinical evidence", World Neurosurg, 83, pp.816~823 (2015)[DOI]
- Qadir R, "Establishing a role for vancomycin powder application for prosthetic joint infection prevention-results of a wear simulation study", J Arthroplasty, 29, pp.1449~1456 (2014)[DOI]
- Everhart JS, "Development and validation of a preoperative surgical site infection risk score for primary or revision knee and hip arthroplasty", J Bone Joint Surg Am, 98, pp.1522~1532 (2016)[DOI]
- Jahng KH, "Risk factors for wound complications after direct anterior approach hip arthroplasty", J Arthroplasty, 31, pp.2583~2587 (2016)[DOI]
- Purcell RL, "Severely obese patients have a higher risk of infection after direct anterior approach total hip arthroplasty", J Arthroplasty, 31(9 Suppl), pp.162~165 (2016)
- Vander Salm TJ, "Reduction of sternal infection by application of topical vancomycin", J Thorac Cardiovasc Surg, 98, pp.618~622 (1989)
- Sweet FA, "Intrawound application of vancomycin for prophylaxis in instrumented thoracolumbar fusions: efficacy, drug levels, and patient outcomes", Spine (Phila Pa 1976), 36, pp.2084~2088 (2011)[DOI]
- O'Neill KR, "Reduced surgical site infections in patients undergoing posterior spinal stabilization of traumatic injuries using vancomycin powder", Spine J, 11, pp.641~646 (2011)[DOI]
- Strom RG, "Decreased risk of wound infection after posterior cervical fusion with routine local application of vancomycin powder", Spine (Phila Pa 1976), 38, pp.991~994 (2013)[DOI]
- Tubaki VR, "Effects of using intravenous antibiotic only versus local intrawound vancomycin antibiotic powder application in addition to intravenous antibiotics on postoperative infection in spine surgery in 907 patients", Spine (Phila Pa 1976), 38, pp.2149~2155 (2013)[DOI]